Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior

Cell Reports
Samantha J HindleRoland J Bainton

Abstract

Central nervous system (CNS) chemical protection depends upon discrete control of small-molecule access by the blood-brain barrier (BBB). Curiously, some drugs cause CNS side-effects despite negligible transit past the BBB. To investigate this phenomenon, we asked whether the highly BBB-enriched drug efflux transporter MDR1 has dual functions in controlling drug and endogenous molecule CNS homeostasis. If this is true, then brain-impermeable drugs could induce behavioral changes by affecting brain levels of endogenous molecules. Using computational, genetic, and pharmacologic approaches across diverse organisms, we demonstrate that BBB-localized efflux transporters are critical for regulating brain levels of endogenous steroids and steroid-regulated behaviors (sleep in Drosophila and anxiety in mice). Furthermore, we show that MDR1-interacting drugs are associated with anxiety-related behaviors in humans. We propose a general mechanism for common behavioral side effects of prescription drugs: pharmacologically challenging BBB efflux transporters disrupts brain levels of endogenous substrates and implicates the BBB in behavioral regulation.

Citations

Nov 27, 2018·ELife·Gregory ArtiushinAmita Sehgal
Feb 26, 2020·Developmental Neurobiology·Jonas BitternChristian Klämbt
Mar 27, 2020·The Journal of Experimental Medicine·Caterina P ProfaciRichard Daneman
Jul 10, 2019·Communications Biology·Kristen M LeeMike Grotewiel
Apr 26, 2018·Genes & Development·Natasha M O'BrownChenghua Gu
Nov 18, 2018·Glia·Kerem YildirimChristian Klämbt
Feb 23, 2020·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ryann M FameHazel L Sive
Jul 9, 2020·International Journal of Molecular Sciences·Karol Kaiser, Vitezslav Bryja
Feb 6, 2020·Journal of Neurophysiology·R Meldrum RobertsonR David Andrew
Nov 1, 2020·Environmental Science and Pollution Research International·Łukasz NicewiczMirosław Nakonieczny
Jan 14, 2020·Current Biology : CB·Naoki Okamoto, Naoki Yamanaka
Mar 6, 2021·Journal of Internal Medicine·A Ben-Zvi, S Liebner
Jan 12, 2020·Communications Biology·Kristen M LeeMike Grotewiel
Aug 9, 2019·Experimental Eye Research·Jérémie CanonicaFrancine Behar-Cohen
Jun 30, 2019·Trends in Neurosciences·Vishnu Anand CuddapahAmita Sehgal
Jul 3, 2021·International Journal of Molecular Sciences·Oxana Semyachkina-GlushkovskayaJürgen Kurths
Oct 2, 2021·Cellular & Molecular Immunology·Ian Galea
Dec 9, 2021·British Journal of Pharmacology·Francine Behar-Cohen, Min Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
A B De BoerD D Breimer
Clinical Pharmacology and Therapeutics
Christiane Pauli-MagnusDeanna Kroetz
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Shinsuke Nakagawa, Masami Niwa
© 2022 Meta ULC. All rights reserved